Evaxion A (EVAX) Change in Working Capital (2020 - 2022)
Evaxion A (EVAX) reported Change in Working Capital of $427000.0 for Q2 2022, up 42.33% on a YoY basis from $300000.0 in Q2 2021, and up 119.69% quarter-over-quarter from -$2.2 million in Q1 2022.
Evaxion A (EVAX) Change in Working Capital (2020 - 2022) Analysis & Trends
Evaxion A has reported Change in Working Capital for 3 years, with the latest figure at $427000.0 in Q2 2022.
- For the quarter ending Q2 2022, Change in Working Capital rose 42.33% year-over-year to $427000.0; the trailing twelve-month figure through Jun 2022 stood at -$2.0 million (down 248.19% YoY), and the FY2024 full-year result was -$520000.0, up 66.71% from the prior year.
- Change in Working Capital for Q2 2022 stood at $427000.0, up from -$2.2 million in the prior quarter.
- The five-year high for Change in Working Capital was $1.0 million in Q1 2021, with the low at -$2.2 million in Q1 2022.
- Historically, Change in Working Capital has averaged -$165500.0 across 3 years, with a median of $22000.0 in 2020.
- The largest YoY upside for Change in Working Capital was 591.8% in 2021 against a maximum downside of 677.14% in 2021.
- Evaxion A's Change in Working Capital stood at $105000.0 in 2020, then sank by 677.14% to -$606000.0 in 2021, then surged by 170.46% to $427000.0 in 2022.
- The last three Change in Working Capital figures came in at $427000.0 (Q2 2022), -$2.2 million (Q1 2022), and -$606000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 427,000.00 |
| Jun 30, 2022 | 427,000.00 |
| Mar 31, 2022 | -2.17 Mn |
| Mar 31, 2022 | -2.17 Mn |
| Sep 30, 2021 | -606,000.00 |
| Sep 30, 2021 | -606,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 1.04 Mn |
| Mar 31, 2021 | 1.04 Mn |
| Sep 30, 2020 | 105,000.00 |
| Sep 30, 2020 | 105,000.00 |
| Jun 30, 2020 | -61,000.00 |
| Jun 30, 2020 | -61,000.00 |
| Mar 31, 2020 | -358,000.00 |
| Mar 31, 2020 | -358,000.00 |